Patents by Inventor Somberg John

Somberg John has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metolazone emulsion formulation
    Patent number: 12121520
    Abstract: The present invention relates to pharmaceutical formulations comprising metolazone, a lipid, and an emulsifier that provide a lipid formulation of metolazone that can be administered intravenously to patients, thereby enhancing the therapeutic delivery and improving patient care for acute heart failure and resistant edmitious states.
    Type: Grant
    Filed: July 18, 2022
    Date of Patent: October 22, 2024
    Assignee: Hyloris Developments S.A.
    Inventor: Somberg John
  • METOLAZONE EMULSION FORMULATION
    Publication number: 20230018789
    Abstract: The present invention relates to pharmaceutical formulations comprising metolazone, a lipid, and an emulsifier that provide a lipid formulation of metolazone that can be administered intravenously to patients, thereby enhancing the therapeutic delivery and improving patient care for acute heart failure and resistant edmitious states.
    Type: Application
    Filed: July 18, 2022
    Publication date: January 19, 2023
    Inventor: Somberg John
  • Metolazone emulsion formulation
    Patent number: 11389451
    Abstract: The present invention relates to pharmaceutical formulations comprising metolazone, a lipid, and an emulsifier that provide a lipid formulation of metolazone that can be administered intravenously to patients, thereby enhancing the therapeutic delivery and improving patient care for acute heart failure and resistant edmitious states.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: July 19, 2022
    Assignee: HYLORIS DEVELOPMENTS S.A.
    Inventor: Somberg John
  • METOLAZONE EMULSION FORMULATION
    Publication number: 20200179386
    Abstract: The present invention relates to pharmaceutical formulations comprising metolazone, a lipid, and an emulsifier that provide a lipid formulation of metolazone that can be administered intravenously to patients, thereby enhancing the therapeutic delivery and improving patient care for acute heart failure and resistant edmitious states.
    Type: Application
    Filed: September 11, 2018
    Publication date: June 11, 2020
    Inventor: Somberg John